Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorYale University

About this trial

To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chronic pain at Yale.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of chronic pain (generally pain duration of at least 3-6 months) localized to an anatomical region appropriate for cryoneurolysis as determined by the treating physician.

Planned cryoneurolysis procedure as part of standard clinical care.

Ability to provide written informed consent.

Ability and willingness to complete baseline and follow-up questionnaires.

Disqualifiers

Cryoneurolysis performed as part of a separate investigational trial in which data sharing is not permitted.

Active infection or other clinical contraindication to the procedure as determined by the treating clinician.

Life expectancy of less than 12 months in the judgment of the treating clinician.

Any condition that, in the investigator's opinion, would interfere with study participation or completion of follow-up, such as severe psychiatric instability or active substance use that precludes reliable follow-up

Trial population

Adults aged 18 years or older with chronic pain localized to an anatomical region considered appropriate for cryoneurolysis by the treating physician and scheduled to undergo cryoneurolysis as standard clinical care.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

80 Participants
are grouped into 1 trial group
Group A: Participants undergoing cryoneurolysis

Trial outcomes

Primary outcomes

1

Percentage of participants with improvement in pain

Percentage of participants achieving a clinically meaningful improvement in pain. Pain improvement measured as a ≥2-point reduction on the 0-10 Numeric Rating Scale (NRS). NRS is a widely used, validated 0-10, tool for measuring subjective pain intensity, where 0 represents "no pain" and 10 represents "the worst pain imaginable".

Time frame
6 and 12 months
2

Change in Pain Disability Index (PDI) score

PDI is a 7-item self-report questionnaire used to measure how chronic pain interferes with various aspects of a person's life, with total scores ranging from 0 (no disability) to 70 (maximum disability).

Time frame
6 and 12 months

Secondary outcomes

1

Number of pain-related hospital admissions

Number of pain-related hospital admissions in the 12 months before versus the 12 months after cryoneurolysis.

Time frame
up to 12 months post cryoneurolysis
2

Number of pain-related emergency department visits

Number of pain-related emergency department visits in the 12 months before versus the 12 months after cryoneurolysis.

Time frame
up to 12 months post cryoneurolysis
3

Number of pain-related medication refills

Number of pain-related medication refills in the 12 months before versus the 12 months after cryoneurolysis.

Time frame
up to 12 months post cryoneurolysis
4

Number of responders

Responders are participants reporting 'much improved' or 'very much improved' using the Patient Global Impression of Change (PGIC).

Time frame
6 and 12 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.